BioSpace News Archive

-- Study demonstrated that treatment with setmelanotide reduced body weight and hunger in individuals living with Bardet-Biedl syndrome --

Heska Corporation (NASDAQ: HSKA; “Heska” or the “Company”), a leading provider of advanced veterinary diagnostic and specialty products, plans to report its second quarter 2020 financial performance in a press release before the market opens on Tuesday, August 4, 2020 and to host an earnings call to discuss the results following th

El Milagro Clinic announced it has launched rapid COVID-19 testing, together with CVS Health, at its clinic in the Rio Grande Valley.

Atreca, Inc. announced the pricing of its previously announced underwritten public offering of 7,031,250 shares of its Class A Common Stock and 781,250 shares of its Class B Common Stock, each at a price to the public of $16.00 per share.

Tiziana Life Sciences plc, a biotechnology company focused on innovative therapeutics for oncology, inflammation and infectious diseases, is pleased to announce that it has submitted a patent application on potential use of Foralumab, a fully human anti-CD3 monoclonal antibody, to improve success of CAR-T therapy for cancer and other human diseases.

“EvaluatePharma® World Preview 2020, Outlook to 2026” explores biopharma growth drivers, brakes and top performers

The worldwide legionella testing market has a hearty merchant scene and features an escalated challenge, says by Transparency Market Research.

The global hemostasis diagnostics market has been prophesied to bear a largely consolidated characteristic with a high level of rivalry prevailing among top players operating in the industry.

The vendor landscape in the global catheters market is characterized by high degree of consolidation: a few companies with technological expertise and financial might have established their dominance.

The global biochemical reagents market is projected to be positively impacted by mushrooming research and development activities, increasing awareness among patients, and surging prevalence of cancer and neurological, cardiovascular, and infectious diseases.